Adult

Aztreonam with avibactam

Warning

General Information

Monobactam and beta-lactamase inhibitor antibiotic

Do NOT use if patient has a history of severe penicillin allergy.  If in doubt, discuss with Micro/ID.

Restricted formulary antimicrobial: For details see OUH netFormulary

AWaRe antibiotic classification: 'Reserve'. All indications to be discussed with Micro/ID.

Renal and hepatic impairment

Renal impairment

 

Creatinine Clearance (mL/min)*

Dose

Frequency

Loading

Maintenance

51 or over

2.7g

(2g aztreonam / 677mg avibactam)

2g

(1.5g aztreonam / 500mg avibactam)

every 6 hours

30 - 50

2.7g

(2g aztreonam / 677mg avibactam)

1g

(750mg aztreonam / 250mg avibactam)

every 6 hours

16 - 29

1.8g

(1.35g aztreonam / 450mg avibactam)

900mg

(675mg aztreonam / 225mg avibactam)

every 8 hours

15 or less

and on HD/HDF/High flux or PD**

 

HD/HDF/High flux: Dialysed; give post-dialysis on dialysis days

PD: Not dialysed

1.3g

(1g aztreonam / 333mg avibactam)

900mg

(675mg aztreonam / 225mg avibactam)

every 12 hours

*dose ranges use creatinine clearance, rather than eGFR

** Aztreonam-avibactam should not be used in patients with CrCL 15mL/min or less unless haemodialysis or another form of renal replacement therapy is initiated.

 

Hepatic impairment

No dose adjustment required.

Dosing in obesity

No dose adjustment required.

Notable interactions

Please see the BNF, Summary of Product Characteristics or speak to a pharmacist.

Pregnancy and breastfeeding

Pregnancy

Limited or no data for use in pregnant women. Avoid unless benefit to mother outweighs risk to the child. Discuss with Micro/ID and pharmacy.

Breastfeeding

Discuss with pharmacy.

Additional information

Aztreonam and Avibactam 2g vial contains 1.5g Aztreonam & 0.5g Avibactam powder for concentrate for solution for infusion

References

  1. Pfizer Limited. Summary of Product Characteristics (SPC). Emblaveo 1.5 g/0.5 g powder for concentrate for solution for infusion. Last revision of the text: 03/2025. Accessed via www.medicines.org.uk Accessed 08/09/2025
  2. BNF online accessed via www.medicinescomplete.com Accessed 08/09/2025
  3. The Renal Drug Database. EMBLAVEO (aztreonam/avibactam sodium). [online]. Last updated: 27/05/2025. Accessed via https://renaldrugdatabase.com Accessed 08/09/2025

Editorial Information

Next review date: 01 Jul 2028

Author(s): AMST.

Approved By: MMTC